AAPGV (Ascentage) Prakiraan rega marang bathi
Despite geopolitical risks and pressure from US patent law, Ascentage Pharma Group dominates the apoptosis inhibitor segment. Lisoft provides the company with protection through a unique mechanism for destroying cancer cells. The environmental footprint is minimal and limited to the disposal of laboratory waste. The forward P/E multiple for the company clearly demonstrates the valuation dynamics, where 0.00 characterizes this valuation parameter.
Rincian metrik keuangan lan pasar Ascentage (AAPGV)
- nilai saham lan prakiraan konsensus rega:
- indikator valuasi pasar bisnis:
- statistik nilai buku emiten:
- indikator beban utang lan likuiditas:
Utang marang Ekuitas Ascentage Pharma Group|AAPGV - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Ascentage Pharma Group|AAPGV - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Ascentage Pharma Group International|AAPGV - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Ascentage Pharma|Rasio cepet ascentage.com
- statistik bathi lan rasio pasar:
AAPGV - Penghasilan resik|Proyeksi bathi mangsa ngarep Ascentage Pharma Group|AAPGV - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Ascentage Pharma Group Ltd|AAPGV - Rasio P/E diaturake wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Ascentage Pharma Group International|AAPGV - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) Ascentage Pharma|AAPGV - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan ascentage.com|AAPGV - Owah-owahan bathi resik saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Ascentage Pharma Group
- data total pendapatan lan volume dodolan:
Analisis kabeh metrik perusahaan:Ascentage Pharma
Forward P/E reflects the market value of an asset relative to expected annual earnings, allowing for an assessment of whether a security is overbought or undervalued. By analyzing the projected forward P/E of Ascentage Pharma Group (AAPGV), an investor can correlate capitalization growth rates with the commercialization of targeted therapy and the success of apoptosis inhibitor-based drugs, which is critical for valuing the biopharmaceutical developments of Ascentage Pharma Group.
Analisis perusahaan pesaing
Rega marang bathi mangsa ngarep BeiGene (ONC)|HALO (Halozyme Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|RevMed - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi AAPG|CG Oncology, Inc. - Pangali Forward P/E|urogen.com (URGN) - Prakiraan rega marang bathi|BCAX (Bicara Therapeutics) - Prakiraan rega marang bathi|Personalis Inc (PSNL) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Erasca Corp|DCTH: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E YMAB|AURA - Rasio prakiraan rega marang bathi|Pangali Forward P/E CADL (Candel Therapeutics, Inc.)|Pangali Forward P/E Accuray Inc ARAY|SLS - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Actuate Therapeutics Inc ACTU|CTOR: Pangali Forward P/E|Prakiraan rega marang bathi TuHURA Biosciences|TARA (Protara Therapeutics, Inc.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Fate Therapeutics Inc FATE|Rega marang bathi mangsa ngarep Aadi Bioscience Inc (WHWK)|tscan.com - Rasio rega marang bathi mangsa ngarep|Champions Oncology, Inc. - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep XBIT (XBiotech Inc)|CEL-SCI Corp - Pangali Forward P/E|OSTX - Pangali Forward P/E|RADX: Pangali Forward P/E|Pangali forward rega marang bathi Artiva Biotherapeutics ARTV|ANL (Adlai Nortye Ltd) - Pangali Forward P/E|Rasio prakiraan rega marang bathi verupharma.com VERU|Prakiraan rega marang bathi TPST (Tempest Therapeutics, Inc.)|XLO (xiliotx.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Renovaro RENB|MURA (Mural Oncology PLC) - Rasio rega marang bathi sing dikarepake|Kairos Pharma Inc - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi OKUR (OnKure Therapeutics Inc)|GDTC: Pangali Forward P/E|Curis (CRIS) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Apollomics Inc.|THAR: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Advanced Biomed Inc (ADVB)|Prakiraan rega marang bathi genprex.com GNPX|Pangali Forward P/E CLDI (Calidi Biotherapeutics, Inc.)|Pangali Forward P/E Sunshine Biopharma Inc. SBFM|XBIO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi SLRX (Salarius Pharma)|PPBT: Pangali Forward P/E|Pangali forward rega marang bathi American Oncology Network, Inc. AONC|Rega marang bathi mangsa ngarep BeiGene|CKPT: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Elevation Oncology, Inc. (ELEV)|ICAD - Rasio prakiraan rega marang bathi|Ikena Oncology - Prakiraan rega marang bathi|Pangali Forward P/E notablelabs.com NTBL|VIRX - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake MOR|NAYA: Pangali Forward P/E
